OTCPK:IHHH.F

Stock Analysis Report

Executive Summary

IHH Healthcare Berhad, an investment holding company, provides healthcare services worldwide.

Snowflake

Fundamentals

Reasonable growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has IHH Healthcare Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

IHHH.F

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

IHHH.F

-9.1%

US Healthcare

0.6%

US Market

No trading data on IHHH.F.

No trading data on IHHH.F.


Share holder returns

IHHH.FIndustryMarket
7 Day0%-0.04%-0.6%
30 Day-2.3%-0.5%2.2%
90 Dayn/a-1.6%1.1%
1 Yearn/a-7.7%-9.1%2.9%0.6%
3 Year-15.8%-15.8%29.6%24.3%44.6%35.2%
5 Yearn/a66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is IHH Healthcare Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is IHH Healthcare Berhad undervalued based on future cash flows and its price relative to the stock market?

23%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

IHH Healthcare Berhad's share price is below the future cash flow value, and at a moderate discount (> 20%).

IHH Healthcare Berhad's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

IHH Healthcare Berhad is overvalued based on earnings compared to the US Healthcare industry average.

IHH Healthcare Berhad is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

IHH Healthcare Berhad is poor value based on expected growth next year.


Price Based on Value of Assets

IHH Healthcare Berhad is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is IHH Healthcare Berhad expected to perform in the next 1 to 3 years based on estimates from 19 analysts?

24.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

IHH Healthcare Berhad's revenue is expected to grow by 9.8% yearly, however this is not considered high growth (20% yearly).

IHH Healthcare Berhad's earnings are expected to grow significantly at over 20% yearly.

IHH Healthcare Berhad's revenue growth is expected to exceed the United States of America market average.

IHH Healthcare Berhad's earnings growth is expected to exceed the United States of America market average.

IHH Healthcare Berhad's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

IHH Healthcare Berhad is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has IHH Healthcare Berhad performed over the past 5 years?

-9.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

IHH Healthcare Berhad's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.

IHH Healthcare Berhad's 1-year earnings growth exceeds its 5-year average (81.8% vs -9.9%)

IHH Healthcare Berhad's earnings growth has exceeded the US Healthcare industry average in the past year (81.8% vs 5.6%).


Return on Equity

IHH Healthcare Berhad has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

IHH Healthcare Berhad used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

IHH Healthcare Berhad has improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is IHH Healthcare Berhad's financial position?


Financial Position Analysis

IHH Healthcare Berhad is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

IHH Healthcare Berhad's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

IHH Healthcare Berhad's level of debt (32.8%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has increased over the past 5 years (20.6% vs 32.8% today).

Debt is well covered by operating cash flow (21.4%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 6.1x coverage).


Balance Sheet

High level of physical assets or inventory.

Debt is not covered by short term assets, assets are 0.8x debt.


Next Steps

Dividend

What is IHH Healthcare Berhad's current dividend yield, its reliability and sustainability?

0.66%

Expected Dividend Yield


Dividend Yield and Payments Analysis

IHH Healthcare Berhad's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

IHH Healthcare Berhad's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).

IHH Healthcare Berhad is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.

IHH Healthcare Berhad is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.


Current Payout to Shareholders

No need to calculate the sustainability of IHH Healthcare Berhad's dividends as it is not paying a notable one for United States of America.


Future Payout to Shareholders

No need to calculate the sustainability of IHH Healthcare Berhad's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of IHH Healthcare Berhad's salary, the management and board of directors tenure and is there insider trading?

2.5yrs

Average management tenure


CEO

See Leng Tan (54yo)

5.7yrs

Tenure

RM36,175,000

Compensation

Dr. See Leng Tan serves as the Group Chief Executive Officer and Managing Director at Parkway Pantai Limited. Dr. Tan serves as an Advisor at Clearbridge Accelerator. He has been the Chief Executive Office ...


CEO Compensation Analysis

See Leng's remuneration is about average for companies of similar size in United States of America.

See Leng's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.5yrs

Average Tenure

54yo

Average Age

The tenure for the IHH Healthcare Berhad management team is about average.


Board Age and Tenure

2.4yrs

Average Tenure

56yo

Average Age

The average tenure for the IHH Healthcare Berhad board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Soon Teck Low (54yo)

    Group Chief Financial Officer

    • Tenure: 3.7yrs
  • See Leng Tan (54yo)

    CEO, MD & Non-Independent Executive Director

    • Tenure: 5.7yrs
    • Compensation: RM36.18m
  • Mehmet Aydinlar (62yo)

    • Tenure: 0yrs
    • Compensation: RM19.03m
  • Boon Kheng Chan (51yo)

    Group Head of Strategic Planning & Business Development (M&A) and CEO of South East Asia Ops. Div.

    • Tenure: 1.7yrs
  • Suet Wun Lim (59yo)

    Group Chief Operating Officer

    • Tenure: 1.5yrs
  • Ching Voon Seow

    Company Secretary

    • Tenure: 0yrs
  • Nili Shayrina Saat (44yo)

    Head of Risk Management

    • Tenure: 0.8yrs
  • Kelvin Loh (45yo)

    Executive Director

    • Tenure: 0.2yrs
  • Abdul Baba (63yo)

    President of IMU Health Sdn Bhd and C.E.O. & Vice-Chancellor of IMU Education Sdn Bhd

    • Tenure: 3.7yrs
  • Sharon Lin (50yo)

    Group Chief Human Resources Officer

    • Tenure: 2.5yrs

Board Members

  • Shirish Apte (66yo)

    Independent Non-Executive Director

    • Tenure: 5yrs
    • Compensation: RM722.00k
  • Mohammed Bin Hashim (62yo)

    Independent Non Executive Chairman

    • Tenure: 1.7yrs
    • Compensation: RM985.00k
  • See Leng Tan (54yo)

    CEO, MD & Non-Independent Executive Director

    • Tenure: 5.7yrs
    • Compensation: RM36.18m
  • Mehmet Aydinlar (62yo)

    • Tenure: 0yrs
    • Compensation: RM19.03m
  • Jill Watts (60yo)

    Independent Non Executive Director

    • Tenure: 1.4yrs
    • Compensation: RM337.00k
  • Koji Nagatomi (58yo)

    Non Independent & Non Executive Director

    • Tenure: 2.4yrs
    • Compensation: RM295.00k
  • Rossana Binti Ahmad Rashid (53yo)

    Independent Non-Executive Director

    • Tenure: 7.4yrs
    • Compensation: RM867.00k
  • Kelvin Loh (45yo)

    Executive Director

    • Tenure: 0.2yrs
  • Takeshi Saito (47yo)

    Non-Independent & Non-Executive Director

    • Tenure: 0.5yrs
    • Compensation: RM148.00k
  • Chinta Bhagat (50yo)

    Non-Independent Non-Executive Director

    • Tenure: 3yrs
    • Compensation: RM626.00k

Company Information

IHH Healthcare Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IHH Healthcare Berhad
  • Ticker: IHHH.F
  • Exchange: OTCPK
  • Founded: 2010
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: RM50.012b
  • Listing Market Cap: RM11.986b
  • Shares outstanding: 8.77b
  • Website: https://www.ihhhealthcare.com

Number of Employees


Location

  • IHH Healthcare Berhad
  • Pantai Hospital Kuala Lumpur
  • Level 11, Block A
  • Kuala Lumpur
  • Wilayah Persekutuan
  • 59100
  • Malaysia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IHHKLSE (Bursa Malaysia)YesOrdinary SharesMYMYRJul 2012
Q0FSGX (Singapore Exchange)YesOrdinary SharesSGSGDJul 2012
IHHH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJul 2012

Biography

IHH Healthcare Berhad, an investment holding company, provides healthcare services worldwide. The company operates in seven segments: Singapore, Malaysia, India, North Asia, Acibadem Holdings, IMU Health,  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:31
End of Day Share Price2019/09/12 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.